For example, research on prostate cancer cells has demonstrated that artemisinin inhibits the action of the cell cycle-regulatory protein pRb by disrupting a complex formed among pRb, E2F transcription factors, and CDKs 122. The gene discussed is RB1; the disease is prostate carcinoma.